BIO-UV Group S.A. (EPA: ALTUV)

BIO-UV Group Statistics

Total Valuation

BIO-UV Group has a market cap or net worth of EUR 16.93 million. The enterprise value is 39.15 million.

Market Cap	16.93M
Enterprise Value	39.15M

Important Dates

The next estimated earnings date is Friday, December 20, 2024.

Earnings Date	Dec 20, 2024
Ex-Dividend Date	n/a

Share Statistics

BIO-UV Group has 10.20 million shares outstanding. The number of shares has decreased by -4.14% in one year.

Current Share Class	n/a
Shares Outstanding	10.20M
Shares Change (YoY)	-4.14%
Shares Change (QoQ)	+2.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	10.83%
Float	10.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.42
PB Ratio	0.51
P/TBV Ratio	n/a
P/FCF Ratio	3.09
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.01, with an EV/FCF ratio of 7.14.

EV / Earnings	-54.05
EV / Sales	0.98
EV / EBITDA	16.01
EV / EBIT	19.11
EV / FCF	7.14

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.78.

Current Ratio	1.69
Quick Ratio	0.83
Debt / Equity	0.78
Debt / EBITDA	10.48
Debt / FCF	4.67
Interest Coverage	2.00

Financial Efficiency

Return on equity (ROE) is -2.20% and return on invested capital (ROIC) is 2.16%.

Return on Equity (ROE)	-2.20%
Return on Assets (ROA)	1.82%
Return on Capital (ROIC)	2.16%
Revenue Per Employee	257,631
Profits Per Employee	-4,673
Employee Count	160
Asset Turnover	0.57
Inventory Turnover	1.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.61% in the last 52 weeks. The beta is 0.41, so BIO-UV Group's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-30.61%
50-Day Moving Average	1.92
200-Day Moving Average	2.19
Relative Strength Index (RSI)	13.93
Average Volume (20 Days)	14,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIO-UV Group had revenue of EUR 39.93 million and -724,377 in losses. Loss per share was -0.07.

Revenue	39.93M
Gross Profit	24.66M
Operating Income	2.05M
Pretax Income	-1.04M
Net Income	-724,377
EBITDA	2.45M
EBIT	2.05M
Loss Per Share	-0.07

Balance Sheet

The company has 3.42 million in cash and 25.63 million in debt, giving a net cash position of -22.22 million or -2.18 per share.

Cash & Cash Equivalents	3.42M
Total Debt	25.63M
Net Cash	-22.22M
Net Cash Per Share	-2.18
Equity (Book Value)	32.94M
Book Value Per Share	3.23
Working Capital	10.64M

Cash Flow

In the last 12 months, operating cash flow was 6.93 million and capital expenditures -1.44 million, giving a free cash flow of 5.49 million.

Operating Cash Flow	6.93M
Capital Expenditures	-1.44M
Free Cash Flow	5.49M
FCF Per Share	0.54

Margins

Gross margin is 61.75%, with operating and profit margins of 5.13% and -1.81%.

Gross Margin	61.75%
Operating Margin	5.13%
Pretax Margin	-2.61%
Profit Margin	-1.81%
EBITDA Margin	6.12%
EBIT Margin	5.13%
FCF Margin	13.74%

Dividends & Yields

BIO-UV Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	4.14%
Shareholder Yield	4.14%
Earnings Yield	-4.28%
FCF Yield	32.40%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIO-UV Group has an Altman Z-Score of 1.34. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.34
Piotroski F-Score	n/a